You are here


ISABEL Now Formats To Your Mobile Device

ISABEL has upgraded their platform to provide a better mobile access experience. The changes allow you access to a fully compatible system on your mobile devices, laptops, tablets, etc. In addition, the latest version provides access to more robust resources like Merck Manual Professional and Medscape on all devices. You can use new features like the Likelihood Indicator as well as take advantage of the Causative Drugs feature on all devices.

An app is no longer required for mobile access. Simply access ISABEL from the CKN website on your phone or tablet from the Point of Care page. You will not be required to enter any additional institutional login details.


New 7th Edition of Australian Injectable Drugs Handbook

The new 7th Edition of the Australian Injectable Drugs Handbook (AIDH) is now available online on CKN.

The most comprehensive resource of its kind, the AIDH provides up-to-date information on injectable medicines that has become a vital resource supporting the day to day practice of pharmacists, clinicians
and nurses throughout Australia.

New features of the AIDH 7th Edition:

  • 450 Injectable Medicines (all entries fully revised)
  • 65 Antineoplastic Medicines
  • 23 New Monographs
  • 5 Antivenoms
  • Increased focus on warnings and patient monitoring
  • Expanded content on extravasation, intravenous fluids and sample infusion-rate calculations
  • A new layout for monographs
  • Easily identifiable antineoplastic monographs, now listed alphabetically with other monographs
  • Indexed and searchable supporting material
  • Device responsive

New on CKN: PDQ (Physician Data Query) Cancer Information

Content from the National Cancer Institute's (NCI) comprehensive source of cancer information, PDQ (Physician Data Query), is now searchable on CKN.

PDQ contains cancer information summaries on a wide range of cancer topics; drug information summaries on many cancer-related drugs and drug combinations; and dictionaries of general cancer terms, drug terms, and genetics terms. More than 14,000 full-text records are now searchable on CKN.

NCI also has several unique cancer resources, such as the NCI Drug Dictionary and NCI Dictionary of Genetics Terms.


Pregnancy and Breastfeeding Medicines Guide

Four new medicine profiles of atumumab, pembrolizumab, pomalidomide and vandetanib have been added online. Dosulepin (dothiepin) and doxepin medicine fact sheets have been added to the medicine profiles. All fact sheets aim to complement verbal counselling by healthcare professionals. All 60 endocrine medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.


Pregnancy and Breastfeeding Medicine Guide

Three new medicine profiles brentuximab vedotinenzalutamide and eribulin have been added online.

A new therapeutic group: Non-cytotoxic antineoplastics - Targeted agents has been added to the website. This aims to provide general advice on the use of targeted agents in pregnancy and breastfeeding.

All 16 allergy and anaphylaxis medicine profiles, 9 antidote medicine profiles and 18 diagnostic imaging contrast media profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.


Tropical Cyclone Debbie

CKN is designed to remain operational 24/7 during extreme weather events. Even if QHEPS is temporarily unavailable at your hospital, CKN will still be accessible via the internet using a personal mobile device. If you or colleagues are not already registered for CKN mobile access, we recommend that you do so as soon as practicable.  Registering is easy and only takes a few minutes.

How do I register?

I think I might already be registered – how do I check?

I’m registered but have forgotten my password


Pregnancy and Breastfeeding Medicine Guide - Updates

New medicine profiles added
Four new medicine profiles, crizotinib, perampanel, romidepsin and vismodegib have been added online.

New patient fact sheets added
Two patient fact sheets, lamotrigine and valproate have been added to the medicine profiles.

Neurological medicine profiles revised
All 53 neurological medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.


Therapeutic Guidelines eTG complete - Rheumatology 3

The March 2017 release of eTG complete includes a comprehensive revision of the Rheumatology topics. Advice is given on the assessment of patients presenting with musculoskeletal symptoms, including the judicious use of investigations, as well as the management of patients with confirmed diagnoses. The guidelines emphasise collaborative, multidisciplinary care of patients with rheumatological diseases. New topics give practical advice on managing analgesic and anti-inflammatory therapy and immunomodulatory therapy for rheumatological conditions.

For more information on Rheumatology 3, please click here to see What’s New brochure or visit our website at



BMJ Best Practice – New mobile app

The updated BMJ Best Practice app has a new user interface and an enhanced search available online and offline. It also takes up less space on devices. Access here. The new app is available to all Queensland Health clinicians. To download the app you will need to have a “personal account” with BMJ Best Practice. For more information, go to CKN’s Mobile Resources page.


DynaMed Plus outscored all point-of-care reference competitors, including UpToDate®, for overall product quality in KLAS 2016 CDS report. Again.

With any major purchase or investment in your life it’s important to do your homework. You gather information to educate and empower you to make the right purchasing decision for you, your family and your life. The common factor in these purchases? Quality. This same kind of thought process also happens inside the world of hospitals. Purchasing and investing in tools for doctors to find the right information to help treat and care for patients can be extremely overwhelming. Many of those individuals or teams that are responsible for buying these products follow the same course of action that we do as consumers when faced with a significant purchase.